+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

From
Pregabalin Market - Global Strategic Business Report - Product Thumbnail Image

Pregabalin Market - Global Strategic Business Report

  • Report
  • September 2026
  • 372 Pages
  • Global
From
Neuropathic Pain Market - Global Strategic Business Report - Product Thumbnail Image

Neuropathic Pain Market - Global Strategic Business Report

  • Report
  • September 2026
  • 386 Pages
  • Global
From
Oxycodone Hydrochloride Market - Global Strategic Business Report - Product Thumbnail Image

Oxycodone Hydrochloride Market - Global Strategic Business Report

  • Report
  • September 2026
  • 361 Pages
  • Global
From
Diabetic Neuropathic Pain Market - Global Strategic Business Report - Product Thumbnail Image

Diabetic Neuropathic Pain Market - Global Strategic Business Report

  • Report
  • September 2026
  • 384 Pages
  • Global
From
Cancer Pain Management Market - Global Strategic Business Report - Product Thumbnail Image

Cancer Pain Management Market - Global Strategic Business Report

  • Report
  • September 2026
  • 588 Pages
  • Global
From
From
Gabapentin - Global Strategic Business Report - Product Thumbnail Image

Gabapentin - Global Strategic Business Report

  • Report
  • September 2026
  • 477 Pages
  • Global
From
Pain Management Drugs - Global Strategic Business Report - Product Thumbnail Image

Pain Management Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 326 Pages
  • Global
From
Non-opioid Pain Patch - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Patch - Global Strategic Business Report

  • Report
  • September 2026
  • 483 Pages
  • Global
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • September 2026
  • 482 Pages
  • Global
From
Prescription Pain Medication Market Report 2026 - Product Thumbnail Image

Prescription Pain Medication Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Chronic Pain Treatment Market Report 2026 - Product Thumbnail Image

Chronic Pain Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Pain Management Market Report 2026 - Product Thumbnail Image

Pain Management Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Gabapentin Market Report 2026 - Product Thumbnail Image

Gabapentin Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Chronic Pain Market Report 2026 - Product Thumbnail Image

Chronic Pain Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-Opioid Pain Patch Market Report 2026 - Product Thumbnail Image

Non-Opioid Pain Patch Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Pain Management Drugs Market Report 2026 - Product Thumbnail Image

Pain Management Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-Steroidal Anti-inflammatory Drugs Market Report 2026 - Product Thumbnail Image

Non-Steroidal Anti-inflammatory Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-Opioid Pain Management Market Global Report 2026 - Product Thumbnail Image

Non-Opioid Pain Management Market Global Report 2026

  • Report
  • August 2026
  • 250 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more